

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | biotin metabolic process (GO:0006768) | 7.93450450 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 7.72633410 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 7.51540267 |
| 4 | fatty acid transmembrane transport (GO:1902001) | 6.59916208 |
| 5 | white fat cell differentiation (GO:0050872) | 6.56176354 |
| 6 | carnitine shuttle (GO:0006853) | 6.33428032 |
| 7 | brown fat cell differentiation (GO:0050873) | 6.21320057 |
| 8 | * triglyceride catabolic process (GO:0019433) | 6.21181214 |
| 9 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 5.95146673 |
| 10 | * triglyceride biosynthetic process (GO:0019432) | 5.80599408 |
| 11 | acyl-CoA biosynthetic process (GO:0071616) | 5.74827543 |
| 12 | thioester biosynthetic process (GO:0035384) | 5.74827543 |
| 13 | * neutral lipid catabolic process (GO:0046461) | 5.72801972 |
| 14 | * acylglycerol catabolic process (GO:0046464) | 5.72801972 |
| 15 | valine metabolic process (GO:0006573) | 5.71471456 |
| 16 | * neutral lipid biosynthetic process (GO:0046460) | 5.56665315 |
| 17 | * acylglycerol biosynthetic process (GO:0046463) | 5.56665315 |
| 18 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.51528084 |
| 19 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 5.48933191 |
| 20 | acetyl-CoA metabolic process (GO:0006084) | 5.39534188 |
| 21 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.32072719 |
| 22 | fatty acid beta-oxidation (GO:0006635) | 5.26632364 |
| 23 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.21277305 |
| 24 | positive regulation of fatty acid oxidation (GO:0046321) | 5.19383265 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.02196375 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.93976216 |
| 27 | exogenous drug catabolic process (GO:0042738) | 4.89777087 |
| 28 | carnitine transmembrane transport (GO:1902603) | 4.85351364 |
| 29 | coenzyme A biosynthetic process (GO:0015937) | 4.67963691 |
| 30 | fatty acid oxidation (GO:0019395) | 4.66156017 |
| 31 | drug catabolic process (GO:0042737) | 4.62356697 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.61725422 |
| 33 | regulation of cholesterol storage (GO:0010885) | 4.59650527 |
| 34 | lipid oxidation (GO:0034440) | 4.58061246 |
| 35 | acylglycerol homeostasis (GO:0055090) | 4.56618778 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.56618778 |
| 37 | fatty acid catabolic process (GO:0009062) | 4.54856452 |
| 38 | fatty acid homeostasis (GO:0055089) | 4.54680916 |
| 39 | branched-chain amino acid catabolic process (GO:0009083) | 4.49437402 |
| 40 | * triglyceride metabolic process (GO:0006641) | 4.47749015 |
| 41 | amino-acid betaine transport (GO:0015838) | 4.47069623 |
| 42 | carnitine transport (GO:0015879) | 4.47069623 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 4.46903319 |
| 44 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.45873095 |
| 45 | branched-chain amino acid metabolic process (GO:0009081) | 4.44487376 |
| 46 | lipid particle organization (GO:0034389) | 4.41536880 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.41405953 |
| 48 | lipid storage (GO:0019915) | 4.40514018 |
| 49 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.40317190 |
| 50 | * glycerolipid catabolic process (GO:0046503) | 4.39941065 |
| 51 | positive regulation of lipid catabolic process (GO:0050996) | 4.34976524 |
| 52 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.24391493 |
| 53 | * acylglycerol metabolic process (GO:0006639) | 4.20325015 |
| 54 | * neutral lipid metabolic process (GO:0006638) | 4.14661637 |
| 55 | response to dietary excess (GO:0002021) | 4.14569087 |
| 56 | regulation of fibrinolysis (GO:0051917) | 4.08134186 |
| 57 | regulation of fatty acid oxidation (GO:0046320) | 4.06232141 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 4.06059320 |
| 59 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.05925078 |
| 60 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.05525420 |
| 61 | pantothenate metabolic process (GO:0015939) | 4.00378169 |
| 62 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.96875675 |
| 63 | omega-hydroxylase P450 pathway (GO:0097267) | 3.94226067 |
| 64 | glycine metabolic process (GO:0006544) | 3.91889396 |
| 65 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.78341447 |
| 66 | negative regulation of fibrinolysis (GO:0051918) | 3.77279218 |
| 67 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.76677052 |
| 68 | cholesterol biosynthetic process (GO:0006695) | 3.76509322 |
| 69 | behavioral response to nicotine (GO:0035095) | 3.76080503 |
| 70 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.72486733 |
| 71 | coenzyme A metabolic process (GO:0015936) | 3.69557976 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.68494587 |
| 73 | L-phenylalanine catabolic process (GO:0006559) | 3.68494587 |
| 74 | acyl-CoA metabolic process (GO:0006637) | 3.67685924 |
| 75 | thioester metabolic process (GO:0035383) | 3.67685924 |
| 76 | heme transport (GO:0015886) | 3.67596965 |
| 77 | monocarboxylic acid catabolic process (GO:0072329) | 3.67418737 |
| 78 | regulation of triglyceride metabolic process (GO:0090207) | 3.61103610 |
| 79 | intracellular lipid transport (GO:0032365) | 3.57174736 |
| 80 | cellular response to lithium ion (GO:0071285) | 3.55949823 |
| 81 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.55229244 |
| 82 | sterol biosynthetic process (GO:0016126) | 3.51829066 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 3.50869902 |
| 84 | glycerol metabolic process (GO:0006071) | 3.49009088 |
| 85 | linoleic acid metabolic process (GO:0043651) | 3.46639929 |
| 86 | oxidative demethylation (GO:0070989) | 3.45880216 |
| 87 | negative regulation of sterol transport (GO:0032372) | 3.45724636 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.45724636 |
| 89 | nucleobase catabolic process (GO:0046113) | 3.45187645 |
| 90 | short-chain fatty acid metabolic process (GO:0046459) | 3.44848596 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.44638074 |
| 92 | NADH metabolic process (GO:0006734) | 3.43820116 |
| 93 | aromatic amino acid family catabolic process (GO:0009074) | 3.41317554 |
| 94 | long-chain fatty acid transport (GO:0015909) | 3.40554052 |
| 95 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.39865095 |
| 96 | negative regulation of response to food (GO:0032096) | 3.38558935 |
| 97 | negative regulation of appetite (GO:0032099) | 3.38558935 |
| 98 | high-density lipoprotein particle remodeling (GO:0034375) | 3.35755937 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 3.35057734 |
| 100 | complement activation, alternative pathway (GO:0006957) | 3.33809436 |
| 101 | quaternary ammonium group transport (GO:0015697) | 3.32690860 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.31433538 |
| 103 | protein carboxylation (GO:0018214) | 3.31433538 |
| 104 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.30379344 |
| 105 | positive regulation of lipid storage (GO:0010884) | 3.29653669 |
| 106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28079311 |
| 107 | diacylglycerol metabolic process (GO:0046339) | 3.24672212 |
| 108 | cysteine metabolic process (GO:0006534) | 3.22680184 |
| 109 | ovulation from ovarian follicle (GO:0001542) | 3.22534210 |
| 110 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.21602955 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.21293626 |
| 112 | proline biosynthetic process (GO:0006561) | 3.20591746 |
| 113 | alanine transport (GO:0032328) | 3.19999589 |
| 114 | NADP metabolic process (GO:0006739) | 3.19328783 |
| 115 | indole-containing compound catabolic process (GO:0042436) | 3.17160192 |
| 116 | indolalkylamine catabolic process (GO:0046218) | 3.17160192 |
| 117 | tryptophan catabolic process (GO:0006569) | 3.17160192 |
| 118 | protein heterotrimerization (GO:0070208) | 3.15318439 |
| 119 | alditol metabolic process (GO:0019400) | 3.14085879 |
| 120 | regulation of sterol transport (GO:0032371) | 3.11503279 |
| 121 | regulation of cholesterol transport (GO:0032374) | 3.11503279 |
| 122 | regulation of protein activation cascade (GO:2000257) | 3.11126956 |
| 123 | positive regulation of cholesterol transport (GO:0032376) | 3.10992074 |
| 124 | positive regulation of sterol transport (GO:0032373) | 3.10992074 |
| 125 | * cellular lipid catabolic process (GO:0044242) | 3.10805738 |
| 126 | carnitine metabolic process (GO:0009437) | 3.09163133 |
| 127 | L-serine metabolic process (GO:0006563) | 3.09102738 |
| 128 | positive regulation of cholesterol efflux (GO:0010875) | 3.08982211 |
| 129 | phosphatidic acid metabolic process (GO:0046473) | 3.07758232 |
| 130 | phosphatidic acid biosynthetic process (GO:0006654) | 3.07758232 |
| 131 | isoprenoid biosynthetic process (GO:0008299) | 3.07623130 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 3.05598067 |
| 133 | reverse cholesterol transport (GO:0043691) | 3.04584233 |
| 134 | tricarboxylic acid metabolic process (GO:0072350) | 3.04088886 |
| 135 | alpha-amino acid catabolic process (GO:1901606) | 3.04081254 |
| 136 | intestinal cholesterol absorption (GO:0030299) | 3.03688671 |
| 137 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.03599090 |
| 138 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.03567914 |
| 139 | bile acid biosynthetic process (GO:0006699) | 3.03216231 |
| 140 | arginine metabolic process (GO:0006525) | 3.03103897 |
| 141 | kynurenine metabolic process (GO:0070189) | 3.02612988 |
| 142 | amino-acid betaine metabolic process (GO:0006577) | 3.02532849 |
| 143 | L-phenylalanine metabolic process (GO:0006558) | 3.01615806 |
| 144 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.01615806 |
| 145 | cellular glucuronidation (GO:0052695) | 2.98699872 |
| 146 | aldehyde catabolic process (GO:0046185) | 2.98500204 |
| 147 | drug metabolic process (GO:0017144) | 2.98055642 |
| 148 | glucuronate metabolic process (GO:0019585) | 2.96710518 |
| 149 | uronic acid metabolic process (GO:0006063) | 2.96710518 |
| 150 | plasma lipoprotein particle remodeling (GO:0034369) | 2.95029984 |
| 151 | protein-lipid complex remodeling (GO:0034368) | 2.95029984 |
| 152 | macromolecular complex remodeling (GO:0034367) | 2.95029984 |
| 153 | cellular ketone body metabolic process (GO:0046950) | 2.91824951 |
| 154 | ethanol oxidation (GO:0006069) | 2.89009653 |
| 155 | L-methionine salvage (GO:0071267) | 2.88778737 |
| 156 | L-methionine biosynthetic process (GO:0071265) | 2.88778737 |
| 157 | amino acid salvage (GO:0043102) | 2.88778737 |
| 158 | fibrinolysis (GO:0042730) | 2.85721287 |
| 159 | regulation of complement activation (GO:0030449) | 2.85627315 |
| 160 | regulation of plasminogen activation (GO:0010755) | 2.84125817 |
| 161 | S-adenosylmethionine metabolic process (GO:0046500) | 2.82468077 |
| 162 | tryptophan metabolic process (GO:0006568) | 2.78506329 |
| 163 | iron coordination entity transport (GO:1901678) | 2.74016197 |
| 164 | cholesterol efflux (GO:0033344) | 2.73904134 |
| 165 | ketone body metabolic process (GO:1902224) | 2.70875002 |
| 166 | phospholipid efflux (GO:0033700) | 2.69403920 |
| 167 | cellular amino acid catabolic process (GO:0009063) | 2.66384640 |
| 168 | C4-dicarboxylate transport (GO:0015740) | 2.66341371 |
| 169 | lysine catabolic process (GO:0006554) | 2.64999152 |
| 170 | lysine metabolic process (GO:0006553) | 2.64999152 |
| 171 | phospholipid homeostasis (GO:0055091) | 2.62996915 |
| 172 | response to pheromone (GO:0019236) | 2.60648724 |
| 173 | bile acid metabolic process (GO:0008206) | 2.59888443 |
| 174 | vitamin biosynthetic process (GO:0009110) | 2.59475103 |
| 175 | alkaloid metabolic process (GO:0009820) | 2.59114178 |
| 176 | regulation of cholesterol esterification (GO:0010872) | 2.57963236 |
| 177 | peptidyl-glutamic acid modification (GO:0018200) | 2.56955624 |
| 178 | arginine catabolic process (GO:0006527) | 2.56595837 |
| 179 | indolalkylamine metabolic process (GO:0006586) | 2.55713555 |
| 180 | aspartate family amino acid catabolic process (GO:0009068) | 2.54827761 |
| 181 | behavioral response to ethanol (GO:0048149) | 2.52784975 |
| 182 | aromatic amino acid family metabolic process (GO:0009072) | 2.50414368 |
| 183 | tyrosine metabolic process (GO:0006570) | 2.49228490 |
| 184 | cellular response to cholesterol (GO:0071397) | 2.48336898 |
| 185 | response to nitrosative stress (GO:0051409) | 2.47254557 |
| 186 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.44306830 |
| 187 | presynaptic membrane assembly (GO:0097105) | 2.40883019 |
| 188 | cellular biogenic amine catabolic process (GO:0042402) | 2.39354326 |
| 189 | amine catabolic process (GO:0009310) | 2.39354326 |
| 190 | phenylpropanoid metabolic process (GO:0009698) | 2.39317569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 5.69863911 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.33561492 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.22002803 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.56741020 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48913801 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.47600926 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.34868173 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.09915464 |
| 9 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.01845043 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.90979636 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.72722743 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.62740762 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42719857 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.30968569 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.08073256 |
| 16 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 2.07437352 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.01025800 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 13.1003524 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99690201 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.98831412 |
| 21 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96647992 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94544721 |
| 23 | P300_19829295_ChIP-Seq_ESCs_Human | 1.91570180 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89469437 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.85961072 |
| 26 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.84963427 |
| 27 | EWS_26573619_Chip-Seq_HEK293_Human | 1.81204691 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79515807 |
| 29 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78020577 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76928424 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76768162 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.75963474 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74349283 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71115839 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64791203 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62587220 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61426957 |
| 38 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.59052079 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58902402 |
| 40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55190189 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.55172798 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.54642341 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.53106090 |
| 44 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.51406825 |
| 45 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.46607678 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45347645 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41197916 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.41079199 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38363583 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37258336 |
| 51 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35061326 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35061326 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.33724464 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33678281 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32533473 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30664437 |
| 57 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30521787 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30416612 |
| 59 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30247522 |
| 60 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29956473 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29932593 |
| 62 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.28298498 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.26884223 |
| 64 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26496130 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.26293665 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25593991 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25325522 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24414820 |
| 69 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23537681 |
| 70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23537681 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22985593 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22366957 |
| 73 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22127989 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19890035 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19263496 |
| 76 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19058617 |
| 77 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19058617 |
| 78 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18743996 |
| 79 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18203233 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16965973 |
| 81 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16552238 |
| 82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15889856 |
| 83 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15807719 |
| 84 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15575433 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15479635 |
| 86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.15224582 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15207915 |
| 88 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14840906 |
| 89 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14780294 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13617251 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13428037 |
| 92 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13318914 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12019046 |
| 94 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.11144569 |
| 95 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.09656941 |
| 96 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.09501895 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08621962 |
| 98 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.08565144 |
| 99 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07122668 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06583974 |
| 101 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05065347 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04961343 |
| 103 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04736588 |
| 104 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04636521 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04424466 |
| 106 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.01657357 |
| 107 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01545977 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00801564 |
| 109 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.99887706 |
| 110 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.99850240 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.99622797 |
| 112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99517565 |
| 113 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.99112673 |
| 114 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98662397 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.98411238 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97558120 |
| 117 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97231560 |
| 118 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96584293 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95397814 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95166809 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95158714 |
| 122 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.95011548 |
| 123 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93788449 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93629716 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.92762162 |
| 126 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.92612905 |
| 127 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91533279 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91438397 |
| 129 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.91219211 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90093882 |
| 131 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89257060 |
| 132 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89257060 |
| 133 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89257060 |
| 134 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89072497 |
| 135 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89072497 |
| 136 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.88624021 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88607655 |
| 138 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88283507 |
| 139 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87320934 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86957797 |
| 141 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.86946432 |
| 142 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86555141 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85343872 |
| 144 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.82512822 |
| 145 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.81481044 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80959243 |
| 147 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80910799 |
| 148 | KDM2B_26808549_Chip-Seq_K562_Human | 0.80316881 |
| 149 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.77909782 |
| 150 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.77219992 |
| 151 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76888947 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76671448 |
| 153 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.76446921 |
| 154 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75945843 |
| 155 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.73409590 |
| 156 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73204262 |
| 157 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.71697721 |
| 158 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.71613913 |
| 159 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.71355678 |
| 160 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70925264 |
| 161 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70716076 |
| 162 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.69418135 |
| 163 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.68491827 |
| 164 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.68482891 |
| 165 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.67644685 |
| 166 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.67339309 |
| 167 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.67339309 |
| 168 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.66881180 |
| 169 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.66697558 |
| 170 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65969109 |
| 171 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65949256 |
| 172 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65908812 |
| 173 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.65415723 |
| 174 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.64494610 |
| 175 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.62909119 |
| 176 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.62793649 |
| 177 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.62518083 |
| 178 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62035701 |
| 179 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.60756051 |
| 180 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.60689171 |
| 181 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.60437878 |
| 182 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.59868185 |
| 183 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58523532 |
| 184 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57716225 |
| 185 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.57513497 |
| 186 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.56788834 |
| 187 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.56647270 |
| 188 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.56561775 |
| 189 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.56188755 |
| 190 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.55666551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 7.76497109 |
| 2 | MP0005666_abnormal_adipose_tissue | 5.16596312 |
| 3 | MP0004130_abnormal_muscle_cell | 4.78285229 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 4.76569736 |
| 5 | MP0003195_calcinosis | 3.80423094 |
| 6 | MP0005375_adipose_tissue_phenotype | 3.62191697 |
| 7 | MP0002971_abnormal_brown_adipose | 3.51870292 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51383351 |
| 9 | MP0005365_abnormal_bile_salt | 3.24863440 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.95491062 |
| 11 | MP0009115_abnormal_fat_cell | 2.86929773 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.85967208 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.67170074 |
| 14 | MP0005334_abnormal_fat_pad | 2.62532267 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.61234602 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.54423455 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.49328432 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.42811954 |
| 19 | MP0002970_abnormal_white_adipose | 2.38048888 |
| 20 | MP0000013_abnormal_adipose_tissue | 2.30338253 |
| 21 | MP0000003_abnormal_adipose_tissue | 2.30257511 |
| 22 | MP0005275_abnormal_skin_tensile | 2.28139536 |
| 23 | MP0003890_abnormal_embryonic-extraembry | 2.22998544 |
| 24 | MP0000566_synostosis | 2.21096970 |
| 25 | MP0004133_heterotaxia | 2.18335571 |
| 26 | MP0002796_impaired_skin_barrier | 2.11097774 |
| 27 | MP0005535_abnormal_body_temperature | 2.09656386 |
| 28 | MP0001661_extended_life_span | 2.04891280 |
| 29 | MP0001529_abnormal_vocalization | 2.04825153 |
| 30 | MP0005360_urolithiasis | 2.03821142 |
| 31 | MP0003122_maternal_imprinting | 2.02006939 |
| 32 | MP0003136_yellow_coat_color | 1.93087785 |
| 33 | MP0002102_abnormal_ear_morphology | 1.84521575 |
| 34 | MP0002938_white_spotting | 1.80375527 |
| 35 | MP0000609_abnormal_liver_physiology | 1.75571303 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.74029319 |
| 37 | MP0001984_abnormal_olfaction | 1.59880261 |
| 38 | MP0005187_abnormal_penis_morphology | 1.59625834 |
| 39 | MP0005448_abnormal_energy_balance | 1.59354918 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.57858011 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.54682395 |
| 42 | MP0001293_anophthalmia | 1.54009103 |
| 43 | MP0003880_abnormal_central_pattern | 1.53876264 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.53161727 |
| 45 | MP0000778_abnormal_nervous_system | 1.48888690 |
| 46 | MP0003959_abnormal_lean_body | 1.47538173 |
| 47 | MP0005452_abnormal_adipose_tissue | 1.44666852 |
| 48 | MP0003937_abnormal_limbs/digits/tail_de | 1.44003078 |
| 49 | MP0001764_abnormal_homeostasis | 1.43842027 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.43225797 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.43152055 |
| 52 | MP0002078_abnormal_glucose_homeostasis | 1.40467774 |
| 53 | MP0003283_abnormal_digestive_organ | 1.37595744 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.36066295 |
| 55 | MP0003121_genomic_imprinting | 1.35889360 |
| 56 | MP0003186_abnormal_redox_activity | 1.35445372 |
| 57 | MP0002282_abnormal_trachea_morphology | 1.33579556 |
| 58 | MP0003567_abnormal_fetal_cardiomyocyte | 1.32866932 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.32666721 |
| 60 | MP0003119_abnormal_digestive_system | 1.32221105 |
| 61 | MP0009697_abnormal_copulation | 1.31988135 |
| 62 | MP0003646_muscle_fatigue | 1.31422834 |
| 63 | MP0005332_abnormal_amino_acid | 1.31261371 |
| 64 | MP0003690_abnormal_glial_cell | 1.31136324 |
| 65 | MP0001968_abnormal_touch/_nociception | 1.26292417 |
| 66 | MP0002009_preneoplasia | 1.25443899 |
| 67 | MP0002736_abnormal_nociception_after | 1.25325450 |
| 68 | MP0003011_delayed_dark_adaptation | 1.25227018 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.24459537 |
| 70 | MP0001666_abnormal_nutrient_absorption | 1.23501660 |
| 71 | MP0003315_abnormal_perineum_morphology | 1.22821122 |
| 72 | MP0000049_abnormal_middle_ear | 1.22132633 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.21250907 |
| 74 | MP0002060_abnormal_skin_morphology | 1.20037752 |
| 75 | MP0002332_abnormal_exercise_endurance | 1.19078728 |
| 76 | MP0003718_maternal_effect | 1.16610384 |
| 77 | MP0006036_abnormal_mitochondrial_physio | 1.12326049 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.11625687 |
| 79 | MP0005394_taste/olfaction_phenotype | 1.11281071 |
| 80 | MP0005499_abnormal_olfactory_system | 1.11281071 |
| 81 | MP0009046_muscle_twitch | 1.09556401 |
| 82 | MP0009053_abnormal_anal_canal | 1.07856603 |
| 83 | MP0004142_abnormal_muscle_tone | 1.07372261 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 1.05396009 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.04894680 |
| 86 | MP0002233_abnormal_nose_morphology | 1.04347852 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.04170849 |
| 88 | MP0004233_abnormal_muscle_weight | 1.03627134 |
| 89 | MP0003941_abnormal_skin_development | 1.03587099 |
| 90 | MP0000647_abnormal_sebaceous_gland | 1.03512726 |
| 91 | MP0002638_abnormal_pupillary_reflex | 1.02920502 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02196188 |
| 93 | MP0003828_pulmonary_edema | 1.01748724 |
| 94 | MP0003868_abnormal_feces_composition | 1.01221466 |
| 95 | MP0008775_abnormal_heart_ventricle | 0.99692923 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.98523388 |
| 97 | MP0001881_abnormal_mammary_gland | 0.97915128 |
| 98 | MP0002751_abnormal_autonomic_nervous | 0.97568402 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.96157380 |
| 100 | MP0005647_abnormal_sex_gland | 0.95770564 |
| 101 | MP0003953_abnormal_hormone_level | 0.94529430 |
| 102 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93937736 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.93666254 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.89789936 |
| 105 | MP0005171_absent_coat_pigmentation | 0.89585120 |
| 106 | MP0001286_abnormal_eye_development | 0.89493242 |
| 107 | MP0005391_vision/eye_phenotype | 0.88772385 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.88491544 |
| 109 | MP0001177_atelectasis | 0.88483688 |
| 110 | MP0005501_abnormal_skin_physiology | 0.87040774 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.85879759 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.85814978 |
| 113 | MP0005253_abnormal_eye_physiology | 0.84493011 |
| 114 | MP0009745_abnormal_behavioral_response | 0.83795637 |
| 115 | MP0000372_irregular_coat_pigmentation | 0.83086674 |
| 116 | MP0003045_fibrosis | 0.82933893 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.82081221 |
| 118 | MP0002254_reproductive_system_inflammat | 0.81826427 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.81530061 |
| 120 | MP0002752_abnormal_somatic_nervous | 0.80463661 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.80369322 |
| 122 | MP0005379_endocrine/exocrine_gland_phen | 0.79004578 |
| 123 | MP0006138_congestive_heart_failure | 0.77276201 |
| 124 | MP0002272_abnormal_nervous_system | 0.77029759 |
| 125 | MP0000751_myopathy | 0.75842818 |
| 126 | MP0003938_abnormal_ear_development | 0.75771810 |
| 127 | MP0003724_increased_susceptibility_to | 0.75244847 |
| 128 | MP0003755_abnormal_palate_morphology | 0.74115975 |
| 129 | MP0009840_abnormal_foam_cell | 0.72929451 |
| 130 | MP0001486_abnormal_startle_reflex | 0.70858446 |
| 131 | MP0003942_abnormal_urinary_system | 0.70742809 |
| 132 | MP0002168_other_aberrant_phenotype | 0.70401572 |
| 133 | MP0003123_paternal_imprinting | 0.70112606 |
| 134 | MP0001986_abnormal_taste_sensitivity | 0.69856512 |
| 135 | MP0002572_abnormal_emotion/affect_behav | 0.69780009 |
| 136 | MP0004272_abnormal_basement_membrane | 0.68571241 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.67841965 |
| 138 | MP0000955_abnormal_spinal_cord | 0.67663176 |
| 139 | MP0005423_abnormal_somatic_nervous | 0.67111278 |
| 140 | MP0004885_abnormal_endolymph | 0.67012541 |
| 141 | MP0002184_abnormal_innervation | 0.66779211 |
| 142 | MP0002160_abnormal_reproductive_system | 0.66642150 |
| 143 | MP0004924_abnormal_behavior | 0.66405405 |
| 144 | MP0005386_behavior/neurological_phenoty | 0.66405405 |
| 145 | MP0005330_cardiomyopathy | 0.66404099 |
| 146 | MP0001188_hyperpigmentation | 0.66220233 |
| 147 | MP0000026_abnormal_inner_ear | 0.65703706 |
| 148 | MP0002090_abnormal_vision | 0.65623132 |
| 149 | MP0009780_abnormal_chondrocyte_physiolo | 0.65118542 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.65079167 |
| 151 | MP0003948_abnormal_gas_homeostasis | 0.63837280 |
| 152 | MP0005266_abnormal_metabolism | 0.63444754 |
| 153 | MP0005395_other_phenotype | 0.61772685 |
| 154 | MP0005451_abnormal_body_composition | 0.59184190 |
| 155 | MP0005620_abnormal_muscle_contractility | 0.57740480 |
| 156 | MP0004087_abnormal_muscle_fiber | 0.57133620 |
| 157 | MP0003252_abnormal_bile_duct | 0.56985520 |
| 158 | MP0000343_altered_response_to | 0.56502424 |
| 159 | MP0002269_muscular_atrophy | 0.55777569 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.55302522 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.55266656 |
| 162 | MP0002249_abnormal_larynx_morphology | 0.55134970 |
| 163 | MP0001324_abnormal_eye_pigmentation | 0.53855172 |
| 164 | MP0002069_abnormal_eating/drinking_beha | 0.52731175 |
| 165 | MP0001756_abnormal_urination | 0.51996370 |
| 166 | MP0003221_abnormal_cardiomyocyte_apopto | 0.51573091 |
| 167 | MP0008872_abnormal_physiological_respon | 0.51459364 |
| 168 | MP0004782_abnormal_surfactant_physiolog | 0.50908877 |
| 169 | MP0005058_abnormal_lysosome_morphology | 0.50875588 |
| 170 | MP0005164_abnormal_response_to | 0.50024564 |
| 171 | MP0000639_abnormal_adrenal_gland | 0.49644894 |
| 172 | MP0002108_abnormal_muscle_morphology | 0.48596388 |
| 173 | MP0005385_cardiovascular_system_phenoty | 0.48268995 |
| 174 | MP0001544_abnormal_cardiovascular_syste | 0.48268995 |
| 175 | MP0000598_abnormal_liver_morphology | 0.47421876 |
| 176 | MP0000427_abnormal_hair_cycle | 0.46610401 |
| 177 | MP0005195_abnormal_posterior_eye | 0.46031704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 7.04180727 |
| 2 | Hyperglycinuria (HP:0003108) | 6.87389440 |
| 3 | Acanthosis nigricans (HP:0000956) | 6.30783315 |
| 4 | Abnormality of glycine metabolism (HP:0010895) | 5.70645080 |
| 5 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.70645080 |
| 6 | Hypertriglyceridemia (HP:0002155) | 5.40246290 |
| 7 | Hyperglycinemia (HP:0002154) | 4.66031888 |
| 8 | Pigmentary retinal degeneration (HP:0001146) | 4.50051821 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.36709678 |
| 10 | Growth hormone excess (HP:0000845) | 4.32967290 |
| 11 | Insulin-resistant diabetes mellitus (HP:0000831) | 4.30000081 |
| 12 | Long foot (HP:0001833) | 4.08779473 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.94676704 |
| 14 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.79424017 |
| 15 | Myoglobinuria (HP:0002913) | 3.76566370 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.74532365 |
| 17 | Abnormality of proline metabolism (HP:0010907) | 3.71709600 |
| 18 | Hydroxyprolinuria (HP:0003080) | 3.71709600 |
| 19 | Hyperammonemia (HP:0001987) | 3.70674201 |
| 20 | Ketosis (HP:0001946) | 3.68295891 |
| 21 | Ketoacidosis (HP:0001993) | 3.65477926 |
| 22 | Complement deficiency (HP:0004431) | 3.62789647 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.59076716 |
| 24 | Epidermoid cyst (HP:0200040) | 3.52117520 |
| 25 | Turricephaly (HP:0000262) | 3.40890565 |
| 26 | Xanthomatosis (HP:0000991) | 3.37169500 |
| 27 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31017286 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.22447888 |
| 29 | Myocardial infarction (HP:0001658) | 3.20523569 |
| 30 | Insulin resistance (HP:0000855) | 3.17034517 |
| 31 | Subcapsular cataract (HP:0000523) | 2.99755194 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.97935283 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96726296 |
| 34 | Dicarboxylic aciduria (HP:0003215) | 2.96726296 |
| 35 | Increased muscle lipid content (HP:0009058) | 2.92000608 |
| 36 | Abnormal hemoglobin (HP:0011902) | 2.89822592 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 2.89481555 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.84525699 |
| 39 | Hyperpituitarism (HP:0010514) | 2.84482307 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.83161110 |
| 41 | True hermaphroditism (HP:0010459) | 2.79295144 |
| 42 | Pancreatic fibrosis (HP:0100732) | 2.76942535 |
| 43 | Hemorrhage of the eye (HP:0011885) | 2.72923126 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.71422675 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.71422675 |
| 46 | Pancreatic cysts (HP:0001737) | 2.65218993 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.56281646 |
| 48 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.55561021 |
| 49 | Abnormality of alanine metabolism (HP:0010916) | 2.55561021 |
| 50 | Hyperalaninemia (HP:0003348) | 2.55561021 |
| 51 | Abnormality of complement system (HP:0005339) | 2.55305901 |
| 52 | Difficulty running (HP:0009046) | 2.54150981 |
| 53 | Abnormal biliary tract physiology (HP:0012439) | 2.52617358 |
| 54 | Bile duct proliferation (HP:0001408) | 2.52617358 |
| 55 | Alopecia of scalp (HP:0002293) | 2.51757950 |
| 56 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.51563334 |
| 57 | Nausea (HP:0002018) | 2.51561659 |
| 58 | Hyperthyroidism (HP:0000836) | 2.49893497 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.48510929 |
| 60 | Chronic hepatic failure (HP:0100626) | 2.48093245 |
| 61 | Congenital stationary night blindness (HP:0007642) | 2.43881460 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42755366 |
| 63 | Abnormality of the labia minora (HP:0012880) | 2.42195394 |
| 64 | Multiple enchondromatosis (HP:0005701) | 2.39885246 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.39322523 |
| 66 | Nephronophthisis (HP:0000090) | 2.38065397 |
| 67 | Pancreatitis (HP:0001733) | 2.35594520 |
| 68 | Intestinal atresia (HP:0011100) | 2.34906127 |
| 69 | Large hands (HP:0001176) | 2.34081295 |
| 70 | Septo-optic dysplasia (HP:0100842) | 2.31896084 |
| 71 | Thyroid-stimulating hormone excess (HP:0002925) | 2.31704471 |
| 72 | Lethargy (HP:0001254) | 2.30670912 |
| 73 | Bilateral microphthalmos (HP:0007633) | 2.29380826 |
| 74 | Polyphagia (HP:0002591) | 2.29345305 |
| 75 | Hypotrichosis (HP:0001006) | 2.27614648 |
| 76 | Prenatal maternal abnormality (HP:0002686) | 2.24005763 |
| 77 | Optic nerve hypoplasia (HP:0000609) | 2.23614680 |
| 78 | Anophthalmia (HP:0000528) | 2.21671811 |
| 79 | Bone cyst (HP:0012062) | 2.20626998 |
| 80 | Joint hemorrhage (HP:0005261) | 2.19305819 |
| 81 | Increased connective tissue (HP:0009025) | 2.17771285 |
| 82 | Abolished electroretinogram (ERG) (HP:0000550) | 2.17604969 |
| 83 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.15523195 |
| 84 | Exercise-induced myalgia (HP:0003738) | 2.14880589 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 2.14002797 |
| 86 | Pendular nystagmus (HP:0012043) | 2.13956793 |
| 87 | Humeroradial synostosis (HP:0003041) | 2.13366503 |
| 88 | Synostosis involving the elbow (HP:0003938) | 2.13366503 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 2.12075888 |
| 90 | Hyperglycemia (HP:0003074) | 2.09733113 |
| 91 | Bifid tongue (HP:0010297) | 2.08849422 |
| 92 | Abnormal eating behavior (HP:0100738) | 2.08811671 |
| 93 | Male infertility (HP:0003251) | 2.08628210 |
| 94 | Sclerocornea (HP:0000647) | 2.07177713 |
| 95 | Intrahepatic cholestasis (HP:0001406) | 2.06680055 |
| 96 | Skin nodule (HP:0200036) | 2.06491430 |
| 97 | Concave nail (HP:0001598) | 2.06483794 |
| 98 | Type II lissencephaly (HP:0007260) | 2.05787727 |
| 99 | Brushfield spots (HP:0001088) | 2.05253126 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 2.03100862 |
| 101 | Central scotoma (HP:0000603) | 1.98468180 |
| 102 | Generalized aminoaciduria (HP:0002909) | 1.96599801 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 1.96318373 |
| 104 | Clitoromegaly (HP:0000057) | 1.96020762 |
| 105 | Colon cancer (HP:0003003) | 1.95826046 |
| 106 | Renal cortical cysts (HP:0000803) | 1.95111911 |
| 107 | Gastrointestinal atresia (HP:0002589) | 1.94666831 |
| 108 | Deep venous thrombosis (HP:0002625) | 1.93729604 |
| 109 | Genital tract atresia (HP:0001827) | 1.92724993 |
| 110 | Methylmalonic acidemia (HP:0002912) | 1.92564821 |
| 111 | Polycythemia (HP:0001901) | 1.92548656 |
| 112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.92154006 |
| 113 | Lissencephaly (HP:0001339) | 1.91855364 |
| 114 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.91198726 |
| 115 | Abnormality of the ileum (HP:0001549) | 1.90772614 |
| 116 | Abnormality of the renal medulla (HP:0100957) | 1.89023983 |
| 117 | Vaginal atresia (HP:0000148) | 1.88561584 |
| 118 | Limb hypertonia (HP:0002509) | 1.88553449 |
| 119 | Accelerated skeletal maturation (HP:0005616) | 1.88301246 |
| 120 | Drooling (HP:0002307) | 1.88230389 |
| 121 | Cerebral aneurysm (HP:0004944) | 1.87873215 |
| 122 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.86515205 |
| 123 | Decreased muscle mass (HP:0003199) | 1.86462968 |
| 124 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85866038 |
| 125 | Vaginal fistula (HP:0004320) | 1.84536968 |
| 126 | Abnormality of methionine metabolism (HP:0010901) | 1.83330169 |
| 127 | Chorioretinal atrophy (HP:0000533) | 1.83286835 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.83222411 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.83222411 |
| 130 | Hypothermia (HP:0002045) | 1.82377756 |
| 131 | Tetraparesis (HP:0002273) | 1.81495287 |
| 132 | Hypobetalipoproteinemia (HP:0003563) | 1.81203535 |
| 133 | Tubular atrophy (HP:0000092) | 1.80497208 |
| 134 | Spontaneous abortion (HP:0005268) | 1.80236118 |
| 135 | Acute encephalopathy (HP:0006846) | 1.78920437 |
| 136 | Short tibia (HP:0005736) | 1.78450252 |
| 137 | Prominent supraorbital ridges (HP:0000336) | 1.78397682 |
| 138 | Enlarged kidneys (HP:0000105) | 1.77930454 |
| 139 | Vomiting (HP:0002013) | 1.76904565 |
| 140 | Bifid scrotum (HP:0000048) | 1.76781551 |
| 141 | Occipital encephalocele (HP:0002085) | 1.76422575 |
| 142 | Meckel diverticulum (HP:0002245) | 1.75828136 |
| 143 | Increased corneal curvature (HP:0100692) | 1.75603503 |
| 144 | Keratoconus (HP:0000563) | 1.75603503 |
| 145 | Postaxial foot polydactyly (HP:0001830) | 1.74357881 |
| 146 | Hypercortisolism (HP:0001578) | 1.73510888 |
| 147 | Preaxial hand polydactyly (HP:0001177) | 1.73451523 |
| 148 | Abnormality of urine glucose concentration (HP:0011016) | 1.73242153 |
| 149 | Glycosuria (HP:0003076) | 1.73242153 |
| 150 | Cerebellar dysplasia (HP:0007033) | 1.73092128 |
| 151 | Increased IgM level (HP:0003496) | 1.72192857 |
| 152 | Abnormality of purine metabolism (HP:0004352) | 1.72124320 |
| 153 | Muscle stiffness (HP:0003552) | 1.71376623 |
| 154 | Testicular atrophy (HP:0000029) | 1.71293887 |
| 155 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71271071 |
| 156 | Hypophosphatemic rickets (HP:0004912) | 1.71080997 |
| 157 | Gait imbalance (HP:0002141) | 1.70477552 |
| 158 | Neonatal hypoglycemia (HP:0001998) | 1.70317554 |
| 159 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70072561 |
| 160 | Congenital primary aphakia (HP:0007707) | 1.69699504 |
| 161 | Postaxial hand polydactyly (HP:0001162) | 1.69221620 |
| 162 | Dandy-Walker malformation (HP:0001305) | 1.69050576 |
| 163 | Supernumerary spleens (HP:0009799) | 1.68306819 |
| 164 | Polar cataract (HP:0010696) | 1.68241792 |
| 165 | Methylmalonic aciduria (HP:0012120) | 1.67966110 |
| 166 | Metabolic acidosis (HP:0001942) | 1.66645958 |
| 167 | Hypoplastic pelvis (HP:0008839) | 1.66202896 |
| 168 | Abnormality of the lower motor neuron (HP:0002366) | 1.65618028 |
| 169 | Inability to walk (HP:0002540) | 1.65245680 |
| 170 | Hepatoblastoma (HP:0002884) | 1.63942751 |
| 171 | Male pseudohermaphroditism (HP:0000037) | 1.63141603 |
| 172 | Anencephaly (HP:0002323) | 1.63065630 |
| 173 | Labial hypoplasia (HP:0000066) | 1.62611952 |
| 174 | Abnormality of vision evoked potentials (HP:0000649) | 1.62528871 |
| 175 | Cystic liver disease (HP:0006706) | 1.61995004 |
| 176 | Large for gestational age (HP:0001520) | 1.61919950 |
| 177 | Nephrogenic diabetes insipidus (HP:0009806) | 1.61699492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1D | 6.03041872 |
| 2 | CAMK1G | 4.34993201 |
| 3 | MAP3K6 | 3.98657989 |
| 4 | BCKDK | 3.74421054 |
| 5 | SIK1 | 3.73963776 |
| 6 | PINK1 | 3.29338839 |
| 7 | TRIB3 | 3.14724499 |
| 8 | PNCK | 3.09353669 |
| 9 | ICK | 2.95172111 |
| 10 | DDR2 | 2.91020016 |
| 11 | WNK3 | 2.85601243 |
| 12 | PDK4 | 2.57313748 |
| 13 | PDK3 | 2.57313748 |
| 14 | ADRBK2 | 2.49671363 |
| 15 | WNK4 | 2.41881220 |
| 16 | BMPR1B | 2.40231036 |
| 17 | MAP4K2 | 2.34634016 |
| 18 | CASK | 2.26206913 |
| 19 | PRKAA2 | 2.19302599 |
| 20 | TRIM28 | 2.16898533 |
| 21 | ZAK | 2.10619690 |
| 22 | TNIK | 2.06493497 |
| 23 | BCR | 1.95044100 |
| 24 | NUAK1 | 1.89218263 |
| 25 | SRPK1 | 1.82267748 |
| 26 | LATS2 | 1.74896283 |
| 27 | MARK1 | 1.74534838 |
| 28 | CSNK1G2 | 1.73931754 |
| 29 | AKT3 | 1.71516866 |
| 30 | MAPK15 | 1.70841989 |
| 31 | PRKD2 | 1.70052962 |
| 32 | TYRO3 | 1.66234587 |
| 33 | PDK2 | 1.65845804 |
| 34 | RIPK1 | 1.64188876 |
| 35 | CSNK1G3 | 1.58865376 |
| 36 | INSRR | 1.57899820 |
| 37 | PRKAA1 | 1.56709750 |
| 38 | PDGFRA | 1.56688343 |
| 39 | PAK3 | 1.51657929 |
| 40 | MST1R | 1.47913173 |
| 41 | CDK6 | 1.46753793 |
| 42 | CSNK1A1L | 1.43396855 |
| 43 | STK38L | 1.36783930 |
| 44 | PHKG2 | 1.35674759 |
| 45 | PHKG1 | 1.35674759 |
| 46 | LATS1 | 1.34128754 |
| 47 | WEE1 | 1.33184246 |
| 48 | TLK1 | 1.32888166 |
| 49 | PLK2 | 1.32272347 |
| 50 | PLK3 | 1.30972452 |
| 51 | MAPK13 | 1.29081696 |
| 52 | MKNK2 | 1.26260990 |
| 53 | PRKCG | 1.26002859 |
| 54 | ACVR1B | 1.25418468 |
| 55 | TSSK6 | 1.24890890 |
| 56 | NEK1 | 1.21762590 |
| 57 | FGR | 1.21436262 |
| 58 | VRK1 | 1.20774389 |
| 59 | MAP2K7 | 1.19804873 |
| 60 | MKNK1 | 1.19648450 |
| 61 | DYRK3 | 1.19163323 |
| 62 | DAPK1 | 1.18911744 |
| 63 | CDC7 | 1.11383267 |
| 64 | CSK | 1.08748057 |
| 65 | STK39 | 1.07786188 |
| 66 | EPHA4 | 1.05370534 |
| 67 | MAP3K11 | 1.03609536 |
| 68 | CDK9 | 1.03114983 |
| 69 | PBK | 0.99251441 |
| 70 | PRKCE | 0.97792411 |
| 71 | PLK4 | 0.97730879 |
| 72 | BMX | 0.97697075 |
| 73 | MATK | 0.96250339 |
| 74 | MAPK11 | 0.94989228 |
| 75 | ERBB3 | 0.94100093 |
| 76 | PRPF4B | 0.93188311 |
| 77 | GSK3A | 0.92856950 |
| 78 | TRPM7 | 0.92115099 |
| 79 | FLT3 | 0.91659505 |
| 80 | STK38 | 0.90436709 |
| 81 | ERN1 | 0.89058558 |
| 82 | STK16 | 0.88035446 |
| 83 | LMTK2 | 0.84823037 |
| 84 | NTRK2 | 0.83387280 |
| 85 | BRSK2 | 0.82626253 |
| 86 | PLK1 | 0.81931505 |
| 87 | PRKD3 | 0.80674684 |
| 88 | CAMKK2 | 0.80572840 |
| 89 | ADRBK1 | 0.79003355 |
| 90 | YES1 | 0.73762765 |
| 91 | EPHB2 | 0.72438718 |
| 92 | PRKACG | 0.71394160 |
| 93 | NEK2 | 0.69018391 |
| 94 | ERBB4 | 0.68128374 |
| 95 | MAPKAPK3 | 0.67939130 |
| 96 | VRK2 | 0.67394193 |
| 97 | MTOR | 0.66756591 |
| 98 | DYRK1B | 0.65209709 |
| 99 | FGFR2 | 0.65037923 |
| 100 | MAP2K1 | 0.64500857 |
| 101 | TAF1 | 0.64322696 |
| 102 | MINK1 | 0.63069875 |
| 103 | BUB1 | 0.61373440 |
| 104 | CSNK1A1 | 0.60253969 |
| 105 | DYRK1A | 0.59389944 |
| 106 | TGFBR1 | 0.58785182 |
| 107 | TTK | 0.58286189 |
| 108 | ERBB2 | 0.57445054 |
| 109 | PAK6 | 0.57019948 |
| 110 | RPS6KB1 | 0.54819884 |
| 111 | NME1 | 0.54586691 |
| 112 | FGFR3 | 0.54501243 |
| 113 | DAPK2 | 0.53975357 |
| 114 | CSNK1E | 0.53851014 |
| 115 | MAP2K4 | 0.53572539 |
| 116 | CDK3 | 0.53473022 |
| 117 | TAOK2 | 0.53422476 |
| 118 | PDPK1 | 0.52994628 |
| 119 | FGFR4 | 0.50584347 |
| 120 | IRAK3 | 0.50526306 |
| 121 | CAMK2A | 0.48976077 |
| 122 | JAK2 | 0.48885003 |
| 123 | ATR | 0.48694397 |
| 124 | CSNK1D | 0.48687670 |
| 125 | OXSR1 | 0.48093071 |
| 126 | PIK3CA | 0.48076883 |
| 127 | EIF2AK3 | 0.47824017 |
| 128 | STK3 | 0.46856996 |
| 129 | RPS6KA4 | 0.46595093 |
| 130 | ATM | 0.46394388 |
| 131 | LIMK1 | 0.46075567 |
| 132 | CAMK1 | 0.46041681 |
| 133 | PRKCZ | 0.44559988 |
| 134 | CHEK2 | 0.44129639 |
| 135 | CSNK2A1 | 0.40965989 |
| 136 | TNK2 | 0.39744678 |
| 137 | NTRK3 | 0.39178585 |
| 138 | IRAK2 | 0.38407399 |
| 139 | CDC42BPA | 0.37390896 |
| 140 | PTK2B | 0.37331516 |
| 141 | PDGFRB | 0.35703344 |
| 142 | TIE1 | 0.34751491 |
| 143 | INSR | 0.34347175 |
| 144 | FER | 0.33802155 |
| 145 | PRKD1 | 0.33499245 |
| 146 | PDK1 | 0.32389579 |
| 147 | PRKCH | 0.31868609 |
| 148 | FRK | 0.31692044 |
| 149 | MAP3K9 | 0.30356542 |
| 150 | RPS6KA3 | 0.30166103 |
| 151 | UHMK1 | 0.30077704 |
| 152 | CDK4 | 0.29365462 |
| 153 | DYRK2 | 0.29262379 |
| 154 | MAPK12 | 0.29235607 |
| 155 | FGFR1 | 0.28856279 |
| 156 | CSNK1G1 | 0.28100195 |
| 157 | MARK2 | 0.27929195 |
| 158 | JAK1 | 0.27458249 |
| 159 | RPS6KC1 | 0.26863109 |
| 160 | RPS6KL1 | 0.26863109 |
| 161 | PRKACA | 0.26734985 |
| 162 | MAPK3 | 0.26532284 |
| 163 | MET | 0.26051416 |
| 164 | MAPK4 | 0.24986959 |
| 165 | SGK1 | 0.24964935 |
| 166 | EIF2AK2 | 0.23795748 |
| 167 | RPS6KA1 | 0.21423201 |
| 168 | IGF1R | 0.21337929 |
| 169 | GRK1 | 0.21097394 |
| 170 | MAP3K4 | 0.20805478 |
| 171 | AKT1 | 0.19688293 |
| 172 | MAPK10 | 0.19441283 |
| 173 | ABL1 | 0.19288430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 6.01902390 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.23794598 |
| 3 | Fatty acid metabolism_Homo sapiens_hsa01212 | 4.05774318 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.74761763 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.36011534 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87546473 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.73081775 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.70094999 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.63273159 |
| 10 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.45396656 |
| 11 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.28168767 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22838192 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04707418 |
| 14 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.03531093 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.92597710 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.91236914 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75424834 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.68516530 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67839949 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.67385863 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66475698 |
| 22 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.63348533 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.59320851 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.41642733 |
| 25 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.37623701 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32179388 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30373383 |
| 28 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30250950 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25889533 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25397449 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.23409059 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.17270566 |
| 33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17141669 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16506864 |
| 35 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.15383902 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12103116 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09271951 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08239597 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06617257 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03894797 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03746517 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00312441 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99632463 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98105744 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97999248 |
| 46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97062745 |
| 47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97059102 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94853415 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 0.92629661 |
| 50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91899281 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91525077 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.90642033 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84121190 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82167469 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81439046 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80210098 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78775473 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.78640482 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78290984 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.77108491 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.76939740 |
| 62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76068207 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74735783 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73790252 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71786927 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69066114 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68724130 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.67568050 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66084194 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65490443 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.64954624 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64013136 |
| 73 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63330902 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.62727370 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.60016448 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56791072 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54079316 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53423847 |
| 79 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52691813 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.51426370 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51368598 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50631692 |
| 83 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50418369 |
| 84 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.49165347 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45092616 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44575765 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43599602 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43555871 |
| 89 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42186458 |
| 90 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41191399 |
| 91 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.40767947 |
| 92 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39807305 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38847926 |
| 94 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36867129 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.35734440 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35490405 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35472519 |
| 98 | Bile secretion_Homo sapiens_hsa04976 | 0.35285863 |
| 99 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.34759522 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34069740 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.33859178 |
| 102 | RNA degradation_Homo sapiens_hsa03018 | 0.32634057 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32234662 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31388088 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29078367 |
| 106 | Mismatch repair_Homo sapiens_hsa03430 | 0.27567824 |
| 107 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.27438657 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25514152 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25459317 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24409318 |
| 111 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24280444 |
| 112 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24178615 |
| 113 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23792143 |
| 114 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22669455 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.22471557 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15953334 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12374360 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11200803 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.10495434 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.06616047 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.02834075 |
| 122 | Salivary secretion_Homo sapiens_hsa04970 | 0.02179300 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.01498757 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.01091502 |
| 125 | GABAergic synapse_Homo sapiens_hsa04727 | 0.00572463 |
| 126 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | -0.0598130 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0523703 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0429960 |
| 129 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0417480 |
| 130 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0277965 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0266801 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0072202 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | -0.0028752 |

